Regeneron Financial Statements (REGN)
|
|
|
|
Report date
|
|
|
08.02.2021 |
07.02.2022 |
31.12.2022 |
06.02.2023 |
05.02.2024 |
|
31.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
8 497 |
16 072 |
12 173 |
12 173 |
13 117 |
|
13 847 |
|
Operating Income, bln rub |
|
|
3 577 |
8 947 |
4 739 |
4 739 |
4 047 |
|
4 004 |
|
EBITDA, bln rub |
? |
|
3 901 |
9 281 |
4 918 |
5 335 |
4 654 |
|
4 831 |
|
Net profit, bln rub |
? |
|
3 513 |
8 075 |
4 338 |
4 338 |
3 954 |
|
4 655 |
|
|
OCF, bln rub |
? |
|
2 618 |
7 081 |
0.000 |
5 015 |
4 594 |
|
4 247 |
|
CAPEX, bln rub |
? |
|
614.6 |
551.9 |
3 763 |
590.1 |
926.4 |
|
869.8 |
|
FCF, bln rub |
? |
|
2 004 |
6 529 |
3 763 |
4 425 |
3 668 |
|
3 378 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
3 801 |
4 687 |
5 708 |
5 619 |
2 815 |
|
7 478 |
|
Cost of production, bln rub |
|
|
1 120 |
2 438 |
800.0 |
1 560 |
1 816 |
|
2 279 |
|
R&D, bln rub |
|
|
2 735 |
2 908 |
3 593 |
3 593 |
4 439 |
|
4 662 |
|
Interest expenses, bln rub |
|
|
56.9 |
57.3 |
59.4 |
59.4 |
73.0 |
|
63.0 |
|
|
Assets, bln rub |
|
|
17 163 |
25 435 |
29 215 |
29 215 |
33 080 |
|
37 442 |
|
Net Assets, bln rub |
? |
|
11 025 |
18 769 |
22 664 |
22 664 |
25 973 |
|
29 326 |
|
Debt, bln rub |
|
|
2 696 |
2 700 |
1 981 |
2 701 |
2 703 |
|
2 704 |
|
Cash, bln rub |
|
|
6 723 |
12 533 |
14 334 |
14 334 |
10 845 |
|
9 797 |
|
Net debt, bln rub |
|
|
-4 027 |
-9 833 |
-12 353 |
-11 633 |
-8 142 |
|
-7 093 |
|
|
Ordinary share price, rub |
|
|
483.1 |
631.5 |
721.5 |
721.5 |
878.3 |
|
821.8 |
|
Number of ordinary shares, mln |
|
|
107.6 |
105.7 |
107.1 |
107.1 |
106.7 |
|
108.1 |
|
|
Market cap, bln rub |
|
|
51 983 |
66 752 |
77 272 |
77 272 |
93 714 |
|
88 832 |
|
EV, bln rub |
? |
|
47 956 |
56 919 |
64 919 |
65 639 |
85 572 |
|
81 740 |
|
Book value, bln rub |
|
|
11 025 |
11 917 |
21 749 |
21 749 |
24 935 |
|
28 206 |
|
|
EPS, rub |
? |
|
32.7 |
76.4 |
40.5 |
40.5 |
37.1 |
|
43.1 |
|
FCF/share, rub |
|
|
18.6 |
61.8 |
35.1 |
41.3 |
34.4 |
|
31.2 |
|
BV/share, rub |
|
|
102.5 |
112.7 |
203.1 |
203.1 |
233.7 |
|
260.9 |
|
|
EBITDA margin, % |
? |
|
45.9% |
57.7% |
40.4% |
43.8% |
35.5% |
|
34.9% |
|
Net margin, % |
? |
|
41.3% |
50.2% |
35.6% |
35.6% |
30.1% |
|
33.6% |
|
FCF yield, % |
? |
|
3.85% |
9.78% |
4.87% |
5.73% |
3.91% |
|
3.80% |
|
ROE, % |
? |
|
31.9% |
43.0% |
19.1% |
19.1% |
15.2% |
|
15.9% |
|
ROA, % |
? |
|
20.5% |
31.7% |
14.9% |
14.9% |
12.0% |
|
12.4% |
|
|
P/E |
? |
|
14.8 |
8.27 |
17.8 |
17.8 |
23.7 |
|
19.1 |
|
P/FCF |
|
|
25.9 |
10.2 |
20.5 |
17.5 |
25.6 |
|
26.3 |
|
P/S |
? |
|
6.12 |
4.15 |
6.35 |
6.35 |
7.14 |
|
6.42 |
|
P/BV |
? |
|
4.71 |
5.60 |
3.55 |
3.55 |
3.76 |
|
3.15 |
|
EV/EBITDA |
? |
|
12.3 |
6.13 |
13.2 |
12.3 |
18.4 |
|
16.9 |
|
Debt/EBITDA |
|
|
-1.03 |
-1.06 |
-2.51 |
-2.18 |
-1.75 |
|
-1.47 |
|
|
R&D/CAPEX, % |
|
|
445.0% |
526.9% |
95.5% |
608.8% |
479.2% |
|
536.0% |
|
|
CAPEX/Revenue, % |
|
|
7.23% |
3.43% |
30.9% |
4.85% |
7.06% |
|
6.28% |
|
| Regeneron shareholders |
